LXN (Latexin) has been described as a putative tumor suppressor in melanoma28 as its expression was downregulated in most melanoma cells compared with melanocytes and normal skin in 50% of melanoma samples and its promotor was found to be methylated in most melanomas and melanoma cell lines. The gene discussed is LXN; the disease is melanoma.